Status:
UNKNOWN
PROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist Devices
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Left Ventricular Assist Device
Prognosis
Eligibility:
All Genders
18+ years
Brief Summary
Pooling of earlier VO2-studies conducted at the dept. of cardiology, Rigshospitalet, Denmark, and all LVAD centres of the World that wish to participate. The purpose is to investigate the prognostic ...
Detailed Description
Background and purpose: Peak oxygen uptake (pVO2) is used extensively in HF to predict prognosis and time for heart transplantation. Many centers are increasingly measuring pVO2 in LVAD supported HF ...
Eligibility Criteria
Inclusion
- Durable LVAD implantation
- VO2 in stable post implant phase
Exclusion
- No VO2 data available
- Concomittant RVAD (temp/durable device)
Key Trial Info
Start Date :
April 10 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04423562
Start Date
April 10 2020
End Date
December 31 2022
Last Update
June 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, DK, Denmark, 2100